TTAS a new stilbene derivative that induces apoptosis in Leishmania infantum

Experimental Parasitology

Volumn 133, Issue 1, 2013, Pages 37-43

  Tolomeo, Manlio ^a   Roberti, Marinella ^b   Scapozza, Leonardo ^c   Tarantelli, Chiara ^d   Giacomini, Elisa ^b   Titone, Lucina ^a   Saporito, Laura ^a   Di Carlo, Paola ^a   Colomba, Claudia ^a  

^a UNIVERSITY OF PALERMO   (Italy)

^b UNIVERSITY OF BOLOGNA   (Italy)

^c UNIVERSITY OF GENEVA   (Switzerland)

^d UNIVERSITY OF CHIETI   (Italy)

Author keywords

Leishmaniasis; Programmed cell death; Stilbenes; Tubulin

Indexed keywords

3,4',5 TRIMETHOXY 3' AMINO STILBENE; ANTILEISHMANIAL AGENT; BETA TUBULIN; DNA; STIBOGLUCONATE SODIUM; STILBENE DERIVATIVE; UNCLASSIFIED DRUG;

AFFINITY CHROMATOGRAPHY; APOPTOSIS; ARTICLE; CIS TRANS ISOMERISM; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG ACTIVITY; DRUG CYTOTOXICITY; DRUG POTENCY; DRUG PROTEIN BINDING; DRUG TARGETING; FLOW CYTOMETRY; G2 PHASE CELL CYCLE CHECKPOINT; HEMATOPOIETIC CELL; LD 50; LEISHMANIA INFANTUM; LEISHMANICIDAL ACTIVITY; MITOCHONDRIAL MEMBRANE POTENTIAL; NONHUMAN; PARASITE VIABILITY; PRIORITY JOURNAL; PROMASTIGOTE;

ANNEXIN A5; ANTIMONY SODIUM GLUCONATE; ANTIPROTOZOAL AGENTS; APOPTOSIS; CELL DIVISION; CELLS, CULTURED; CHROMATOGRAPHY, AFFINITY; DOSE-RESPONSE RELATIONSHIP, DRUG; ELECTROPHORESIS, POLYACRYLAMIDE GEL; FLOW CYTOMETRY; G2 PHASE; GRANULOCYTE-MACROPHAGE PROGENITOR CELLS; HEMATOPOIETIC STEM CELLS; LEISHMANIA INFANTUM; LETHAL DOSE 50; MEMBRANE POTENTIAL, MITOCHONDRIAL; STILBENES; TUBULIN;

LEISHMANIA INFANTUM; MAMMALIA;

EID: 84870544137     PISSN: 00144894     EISSN: 10902449     Source Type: Journal    
DOI: 10.1016/j.exppara.2012.10.006     Document Type: Article

References (31)

1. Baiocco P., Colotti G., Franceschini S., Ilari A. Molecular basis of antimony treatment in leishmaniasis. J. Med. Chem. 2009, 52:2603-2612.
2. Cao T.M., Durrant D., Tripathi A., Liu J., Tsai S., Kellogg G.E., Simoni D., Lee R.M. Stilbene derivatives that are colchicine-site microtubule inhibitors have antileukemic activity and minimal systemic toxicity. Am. J. Hematol. 2008, 83:390-397.
3. Changtam C., de Koning H.P., Ibrahim H., Sajid M.S., Gould M.K., Suksamrarn A. Curcuminoid analogs with potent activity against Trypanosoma and Leishmania species. Eur. J. Med. Chem. 2010, 45:941-956.
4. Colomba C., Saporito L., Vitale F., Reale S., Vitale G., Casuccio A., Tolomeo M., Maranto D., Rubino R., Di Carlo P., Titone L. Cryptic Leishmania infantum infection in Italian HIV infected patients. BMC Infect. Dis. 2009, 9:199.
5. Croft S.L., Seifert K., Yardley V. Current scenario of drug development for leishmaniasis. Indian J. Med. Res. 2006, 123:399-410.
6. Cruz I., Nieto J., Moreno J., Canavate C., Desjeux P., Alvar J. Leishmania/HIV co-infections in the second decade. Indian J. Med. Res. 2006, 123:357-388.
7. del Olmo E., Armas M.G., Lopez-Perez J.L., Munoz V., Deharo E., San Feliciano A. Leishmanicidal activity of some stilbenoids and related heterocyclic compounds. Bioorg. Med. Chem. Lett. 2001, 11:2123-2126.
8. del Rey B., Ramos A.C., Caballero E., Inchaustti A., Yaluff G., Medarde M., Rojas de Arias A., San Feliciano A. Leishmanicidal activity of combretastatin analogues and heteroanalogues. Bioorg. Med. Chem. Lett. 1999, 9:2711-2714.
9. Duarte N., Kayser O., Abreu P., Ferreira M.J. Antileishmanial activity of piceatannol isolated from Euphorbia lagascae seeds. Phytother. Res. 2008, 22:455-457.
10. Fremont L. Biological effects of resveratrol. Life Sci. 2000, 66:663-673.
11. Getti G.T., Aslam S.N., Humber D.P., Stevenson P.C., Cheke R.A. The effect of cicerfuran, an arylbenzofuran from Cicer bijugum, and related benzofurans and stilbenes on Leishmania aethiopica, L. tropica and L. major. Planta Med. 2006, 72:907-911.
12. Hart J.H. Role of phytostilbenes in decay and disease resistance. Ann. Rev. Phytopathol. 1981, 19:437-458.
13. Herwaldt B.L. Miltefosine-the long-awaited therapy for visceral leishmaniasis?. N. Engl. J. Med. 1999, 341:1840-1842.
14. Juan M.E., Vinardell M.P., Planas J.M. The daily oral administration of high doses of trans-resveratrol to rats for 28days is not harmful. J. Nutr. 2002, 132:257-260.
15. Kedzierski L., Curtis J.M., Kaminska M., Jodynis-Liebert J., Murias M. In vitro antileishmanial activity of resveratrol and its hydroxylated analogues against Leishmania major promastigotes and amastigotes. Parasitol. Res. 2007, 102:91-97.
16. Kuettel S., Mosimann M., Maser P., Kaiser M., Brun R., Scapozza L., Perozz R. Adenosine Kinase of T b. Rhodesiense identified as the putative target of 4-[5-(4-phenoxyphenyl)-2H-pyrazol-3-yl] morpholine using chemical proteomics. PLoS Negl. Trop. Dis. 2009, 3:e506.
17. Marin C., Boutaleb-Charki S., Diaz J.G., Huertas O., Rosales M., Perez-Cordon G., Guitierrez-Sanchez R., Sanchez-Moreno M. Antileishmaniasis activity of flavonoids from Consolida oliveriana. J. Nat. Prod. 2009, 72:1069-1074.
18. Mishra B.B., Kale R.R., Singh R.K., Tiwari V.K. Alkaloids: future prospective to combat leishmaniasis. Fitoterapia 2009, 80:81-90.
19. Mishra B.B., Singh R.K., Srivastava A., Tripathi V.J., Tiwari V.K. Fighting against Leishmaniasis: search of alkaloids as future true potential anti-Leishmanial agents. Mini Rev. Med. Chem. 2009, 9:107-123.
20. Murray H.W., Berman J.D., Davies C.R., Saravia N.G. Advances in leishmaniasis. Lancet 2005, 366:1561-1577.
21. Palumbo E. Current treatment for cutaneous leishmaniasis: a review. Am. J. 2009, 16:178-182.
22. Roberti M., Pizzirani D., Simoni D., Rondanin R., Baruchello R., Bonora C., Buscemi F., Grimaudo S., Tolomeo M. Synthesis and biological evaluation of resveratrol and analogues as apoptosis-inducing agents. J. Med. Chem. 2003, 46:3546-3554.
23. Sen N., Das B.B., Ganguly A., Mukherjee T., Bandyopadhyay S., Majumder H.K. Camptothecin-induced imbalance in intracellular cation homeostasis regulates programmed cell death in unicellular hemoflagellate Leishmania donovani. J. Biol. Chem. 2004, 279:52366-52375.
24. Sen N., Das B.B., Ganguly A., Mukherjee T., Tripathi G., Bandyopadhyay S., Rakshit S., Sen T., Majumder H.K. Camptothecin induced mitochondrial dysfunction leading to programmed cell death in unicellular hemoflagellate Leishmania donovani. Cell Death Differ. 2004, 11:924-936.
25. Sengupta S., Tripathi J., Tandon R., Raje M., Roy R.P., Basu S.K., Mukhopadhyay A. Hemoglobin endocytosis in Leishmania is mediated through a 46-kDa protein located in the flagellar pocket. J. Biol. Chem. 1999, 274:2758-2765.
26. Shen T., Wang X.N., Lou H.X. Natural stilbenes: an overview. Nat. Prod. Rep. 2009, 26:916-935.
27. Singh G., Jayanarayan K.G., Dey C.S. Novobiocin induces apoptosis-like cell death in topoisomerase II over-expressing arsenite resistant Leishmania donovani. Mol. Biochem. Parasitol. 2005, 141:57-69.
28. Susin S.A., Zamzami N., Kroemer G. Mitochondria as regulators of apoptosis: doubt no more. Biochim. Biophys. Acta 1998, 1366:151-165.
29. Tipparaju S.K., Joyasawal S., Pieroni M., Kaiser M., Brun R., Kozikowski A.P. In pursuit of natural product leads: synthesis and biological evaluation of 2-[3-hydroxy-2-[(3-hydroxypyridine-2-carbonyl)amino]phenyl]benzoxazole-4-c arboxylic acid (A-33853) and its analogues: discovery of N-(2-benzoxazol-2-ylphenyl)benzamides as novel antileishmanial chemotypes. J. Med. Chem. 2008, 51:7344-7347.
30. Tolomeo M., Grimaud S., Di Cristina A., Roberti M., Pizzirani D., Meli M., Dusonchet L., Gebbia N., Abbadessa V., Crosta L., Barucchello R., Grisolia G., Invidiata F., Simoni D. Pterostilbene and 3'-hydroxypterostilbene are effective apoptosis-inducing agents in MDR and BCR-ABL-expressing leukemia cells. Int. J. Biochem. Cell Biol. 2005, 37:1709-1726.
31. Young S.L., Chaplin D.J. Combretastatin A4 phosphate: background and current clinical status. Expert Opin. Investig. Drugs 2004, 13:1171-1182.